Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues

키워드

참고문헌 (60)

1. Abu-Rustum NR, "Sentinel lymph node mapping for endometrial cancer : a modern approach to surgical staging", J Natl Compr Canc Netw, 12, pp.288~297 (2014)
2. Burke TW, "Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer : results of a pilot study", Gynecologic Oncology, 62, pp.169~173 (1996)
3. Rossi EC, "A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging(FIRES trial) : a multicentre, prospective, cohort study", Lancet Oncology, 18, pp.384~392 (2017)
4. Ballester M, "Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer : a prospective multicentre study(SENTI-ENDO)", Lancet Oncology, 12, pp.469~476 (2011)
5. Geppert B, "Sentinel lymph node biopsy in endometrial cancer-feasibility, safety and lymphatic complications", Gynecol Oncol, 148, pp.491~498 (2018)
6. Bae HS, "Postoperative lower extremity edema in patients with primary endometrial cancer", Ann Surg Oncol, 23, pp.186~195 (2016)
7. 하형인, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry", Obstetrics & Gynecology Science, 64(5), pp.444~453 (2021), 대한산부인과학회
8. Kim YN, "Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer", Int J Gynecol Cancer, 30, pp.318~324 (2020)
9. Concin N, "ESGO", ESTRO, Int J Gynecol Cancer, pp.2021, 31[DOI]
10. Koh WJ, "Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 16, pp.170~199 (2018)
11. Tschernichovsky R, "The role of lymphadenectomy versus sentinel lymph node biopsy in early-stage endometrial cancer : a review of the literature", Am J Clin Oncol, 39, pp.516~521 (2016)
12. Altman AD, "Canadian high risk endometrial cancer(CHREC)consortium : analyzing the clinical behavior of high risk endometrial cancers", Gynecol Oncol, 139, pp.268~274 (2015)
13. Keiko Saotome, "Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry", Obstetrics & Gynecology Science, 64(1), pp.80~89 (2021), 대한산부인과학회[DOI]
14. Geppert B, "A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer", Gynecol Oncol, 145, pp.256~261 (2017)
15. Yukiharu Todo, "Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis", Journal of Gynecologic Oncology, 28(5), pp.1~10 (2017), 대한부인종양학회[DOI]
16. Tanaka H, "Can we omit para-aorta lymph node dissection in endometrial cancer?", Jpn J Clin Oncol, 36, pp.578~581 (2006)
17. Legros M, "Para-aortic lymph node invasion in high-risk endometrial cancer : performance of 18FDG PETCT", Anticancer Res, 39, pp.619~625 (2019)
18. Touhami O, "Performance of sentinel lymph node(SLN)mapping in high-risk endometrial cancer", Gynecol Oncol, 147, pp.549~553 (2017)
19. Todo Y, "Survival effect of para-aortic lymphadenectomy in endometrial cancer(SEPAL study) : a retrospective cohort analysis", Lancet, 375, pp.1165~1172 (2021)
20. Eoh KJ, "Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging : a novel sentinel lymph node tracer injection procedure", Surg Oncol, 27, pp.514~519 (2018)
21. Solima E, "Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer", Gynecol Oncol, 126, pp.419~423 (2012)
22. Korkmaz V, "Comparison of three different riskstratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus", J Gynecol Oncol, 28, pp.e78~ (2017)
23. Vargas R, "Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis", Gynecol Oncol, 133, pp.216~220 (2014)
24. Colombo N, "Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up", Ann Oncol, 24, pp.vi33~vi38 (2013)
25. Barlin JN, "The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging : beyond removal of blue nodes", Gynecol Oncol, 125, pp.531~535 (2012)
26. Ianieri MM, "Sentinel lymph node biopsy in the treatment of endometrial cancer: why we fail? Results of a prospective multicenter study on the factors associated with failure of node mapping with indocyanine green", Gynecol Obstet Invest, 84, pp.383~389 (2019)
27. Tucker K, "Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution", Int J Gynecol Cancer, 30, pp.346~351 (2020)
28. Moloney K, "Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer", Int J Gynecol Cancer, 31, pp.647~655 (2021)
29. Soliman PT, "A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer", Gynecol Oncol, 146, pp.234~239 (2017)
30. Persson J, "Pelvic Sentinel lymph node detection in highrisk endometrial cancer(SHREC-trial)-the final step towards a paradigm shift in surgical staging", Eur J Cancer, 116, pp.77~85 (2019)
31. Cusimano MC, "Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate-and high-grade endometrial cancer staging", JAMA Surgery, 156, pp.157~164 (2021)
32. Marchocki Z, "Sentinel lymph node biopsy in high-grade endometrial cancer : a systematic review and meta-analysis of performance characteristics", Am J Obstet Gynecol, 225, pp.367.e1~367.e39 (2021)
33. Matsuo K, "Sentinel lymph node biopsy for stage II endometrial cancer : recent utilization and outcome in the United States", Gynecol Oncol, 164, pp.46~52 (2022)
34. Matsuo K, "Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification", Gynecol Oncol, 165, pp.361~368 (2022)
35. Venigalla S, "Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers", Gynecol Oncol, 149, pp.531~538 (2018)
36. Mahdi H, "Prognostic impact of lymphadenectomy in uterine serous cancer", BJOG, 120, pp.384~391 (2013)
37. Guo W, "Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer:a meta-analysis", Medicine(Baltimore), 97, pp.e9520~ (2018)
38. Basaran D, "Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma", Gynecol Oncol, 156, pp.70~76 (2020)
39. Schiavone MB, "Survival of patients with uterine carcinosarcoma undergoing sentinel lymph node mapping", Ann Surg Oncol, 23, pp.196~202 (2016)
40. Allan V, "Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants", J Comp EffRes, 9, pp.603~614 (2020)
41. Schlappe BA, "Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma", Gynecol Oncol, 156, pp.62~69 (2020)
42. Bogani G, "Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in highrisk endometrial cancer patients : results from a multiinstitutional study", Gynecol Oncol, 161, pp.122~129 (2021)
43. Nasioudis D, "Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer", Gynecol Oncol, 159, pp.732~736 (2020)
44. de Boer SM, "Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer(PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3trial", Lancet Oncol, 20, pp.1273~1285 (2019)
45. Baiocchi G, "Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer : an open-label, non-inferiority, randomized trial(ALICE trial)", Int J Gynecol Cancer, 32, pp.676~679 (2022)
46. Jun Guan, "Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial)", Journal of Gynecologic Oncology, 32(4), pp.1~9 (2021), 대한부인종양학회[DOI]
47. Mariani A, "Prospective assessment of lymphatic dissemination in endometrial cancer : a paradigm shift in surgical staging", Gynecol Oncol, 109, pp.11~18 (2008)
48. Ruiz R, "Maximizing sentinel node detection in endometrial cancer with dual cervical and transcervical fundal indocyanine green injection : 5-year single-center prospective study", Eur J Obstet Gynecol Reprod Biol, 261, pp.59~64 (2021)
49. Martinelli F, "Sentinel node mapping in endometrial cancer following hysteroscopic injection of tracers : a single center evaluation over 200 cases", Gynecologic Oncology, 146, pp.525~530 (2017)
50. Ditto A, "Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer : a multicenter prospective randomised controlled trial from the multicenter italian trials in Ovarian cancer(MITO)study group", Eur J Cancer, 140, pp.1~10 (2020)
51. Ferriss JS, "Uterine serous carcinoma : key advances and novel treatment approaches", Int J Gynecol Cancer, 31, pp.1165~1174 (2021)
52. Paño B, "Pathways of lymphatic spread in gynecologic malignancies", Radiographics, 35, pp.916~945 (2015)
53. Kommoss S, "Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series", Ann Oncol, 29, pp.1180~1188 (2018)
54. Jiang P, "Combining clinicopathological parameters and molecular indicators to predict lymph node metastasis in endometrioid type endometrial adenocarcinoma", Front Oncol, 11, pp.682925~ (2021)
55. León-Castillo A, "Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer : impact on prognosis and benefit from adjuvant therapy", J Clin Oncol, 38, pp.3388~3397 (2020)
56. Buras AL, "Stage IIIC endometrial cancer review : current controversies in adjuvant therapy", Gynecol Oncol Rep, 36, pp.100754~ (2021)
57. Forsse D, "Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors : a prospective cohort study", Am J Obstet Gynecol, 226, pp.90.e1~90.e20 (2022)
58. Jumaah AS, "The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma : a systematic review and meta-analysis", PLoS One, 17, pp.e0263585~ (2022)
59. Westin SN, "Carcinoma of the lower uterine segment : a newly described association with lynch syndrome", J Clin Oncol, 26, pp.5965~5971 (2008)
60. O’Malley DM, "Pembrolizumab in patients with microsatellite instability-high advanced endometrial cancer : results from the KEYNOTE-158 study", J Clin Oncol, 40, pp.752~761 (2022)

관련 논문AI추천